Cargando…

Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds

PURPOSE: Medium versus low weight (MW vs LW) chitosan-shelled oxygen-loaded nanodroplets (cOLNDs) and oxygen-free nanodroplets (cOFNDs) were comparatively challenged for biocompatibility on human keratinocytes, for antimicrobial activity against four common infectious agents of chronic wounds (CWs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandras, Narcisa, Argenziano, Monica, Prato, Mauro, Roana, Janira, Luganini, Anna, Allizond, Valeria, Tullio, Vivian, Finesso, Nicole, Comini, Sara, Bressan, Bruno Emilio, Pecoraro, Francesca, Giribaldi, Giuliana, Troia, Adriano, Cavalli, Roberta, Cuffini, Anna Maria, Banche, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015045/
https://www.ncbi.nlm.nih.gov/pubmed/35444418
http://dx.doi.org/10.2147/IJN.S345553
_version_ 1784688302038712320
author Mandras, Narcisa
Argenziano, Monica
Prato, Mauro
Roana, Janira
Luganini, Anna
Allizond, Valeria
Tullio, Vivian
Finesso, Nicole
Comini, Sara
Bressan, Bruno Emilio
Pecoraro, Francesca
Giribaldi, Giuliana
Troia, Adriano
Cavalli, Roberta
Cuffini, Anna Maria
Banche, Giuliana
author_facet Mandras, Narcisa
Argenziano, Monica
Prato, Mauro
Roana, Janira
Luganini, Anna
Allizond, Valeria
Tullio, Vivian
Finesso, Nicole
Comini, Sara
Bressan, Bruno Emilio
Pecoraro, Francesca
Giribaldi, Giuliana
Troia, Adriano
Cavalli, Roberta
Cuffini, Anna Maria
Banche, Giuliana
author_sort Mandras, Narcisa
collection PubMed
description PURPOSE: Medium versus low weight (MW vs LW) chitosan-shelled oxygen-loaded nanodroplets (cOLNDs) and oxygen-free nanodroplets (cOFNDs) were comparatively challenged for biocompatibility on human keratinocytes, for antimicrobial activity against four common infectious agents of chronic wounds (CWs) – methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Candida albicans and C. glabrata – and for their physical interaction with cell walls/membranes. METHODS: cNDs were characterized for morphology and physico-chemical properties by microscopy and dynamic light scattering. In vitro oxygen release from cOLNDs was measured through an oximeter. ND biocompatibility and ability to promote wound healing in human normoxic/hypoxic skin cells were challenged by LDH and MTT assays using keratinocytes. ND antimicrobial activity was investigated by monitoring upon incubation with/without MW or LW cOLNDs/cOFNDs either bacteria or yeast growth over time. The mechanical interaction between NDs and microorganisms was also assessed by confocal microscopy. RESULTS: LW cNDs appeared less toxic to keratinocytes than MW cNDs. Based on cell counts, either MW or LW cOLNDs and cOFNDs displayed long-term antimicrobial efficacy against S. pyogenes, C. albicans, and C. glabrata (up to 24 h), whereas a short-term cytostatic effects against MRSA (up to 6 h) was revealed. The internalization of all ND formulations by all four microorganisms, already after 3 h of incubation, was showed, with the only exception to MW cOLNDs/cOFNDs that adhered to MRSA walls without being internalized even after 24 h. CONCLUSION: cNDs exerted bacteriostatic and fungistatic effects, due to the presence of chitosan in the outer shell and independently of oxygen addition in the inner core. The duration of such effects strictly depends on the characteristics of each microbial species, and not on the molecular weight of chitosan in ND shells. However, LW chitosan was better tolerated by human keratinocytes than MW. For these reasons, the use of LW NDs should be recommended in future research to assess cOLND efficacy for the treatment of infected CWs.
format Online
Article
Text
id pubmed-9015045
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90150452022-04-19 Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds Mandras, Narcisa Argenziano, Monica Prato, Mauro Roana, Janira Luganini, Anna Allizond, Valeria Tullio, Vivian Finesso, Nicole Comini, Sara Bressan, Bruno Emilio Pecoraro, Francesca Giribaldi, Giuliana Troia, Adriano Cavalli, Roberta Cuffini, Anna Maria Banche, Giuliana Int J Nanomedicine Original Research PURPOSE: Medium versus low weight (MW vs LW) chitosan-shelled oxygen-loaded nanodroplets (cOLNDs) and oxygen-free nanodroplets (cOFNDs) were comparatively challenged for biocompatibility on human keratinocytes, for antimicrobial activity against four common infectious agents of chronic wounds (CWs) – methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Candida albicans and C. glabrata – and for their physical interaction with cell walls/membranes. METHODS: cNDs were characterized for morphology and physico-chemical properties by microscopy and dynamic light scattering. In vitro oxygen release from cOLNDs was measured through an oximeter. ND biocompatibility and ability to promote wound healing in human normoxic/hypoxic skin cells were challenged by LDH and MTT assays using keratinocytes. ND antimicrobial activity was investigated by monitoring upon incubation with/without MW or LW cOLNDs/cOFNDs either bacteria or yeast growth over time. The mechanical interaction between NDs and microorganisms was also assessed by confocal microscopy. RESULTS: LW cNDs appeared less toxic to keratinocytes than MW cNDs. Based on cell counts, either MW or LW cOLNDs and cOFNDs displayed long-term antimicrobial efficacy against S. pyogenes, C. albicans, and C. glabrata (up to 24 h), whereas a short-term cytostatic effects against MRSA (up to 6 h) was revealed. The internalization of all ND formulations by all four microorganisms, already after 3 h of incubation, was showed, with the only exception to MW cOLNDs/cOFNDs that adhered to MRSA walls without being internalized even after 24 h. CONCLUSION: cNDs exerted bacteriostatic and fungistatic effects, due to the presence of chitosan in the outer shell and independently of oxygen addition in the inner core. The duration of such effects strictly depends on the characteristics of each microbial species, and not on the molecular weight of chitosan in ND shells. However, LW chitosan was better tolerated by human keratinocytes than MW. For these reasons, the use of LW NDs should be recommended in future research to assess cOLND efficacy for the treatment of infected CWs. Dove 2022-04-14 /pmc/articles/PMC9015045/ /pubmed/35444418 http://dx.doi.org/10.2147/IJN.S345553 Text en © 2022 Mandras et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mandras, Narcisa
Argenziano, Monica
Prato, Mauro
Roana, Janira
Luganini, Anna
Allizond, Valeria
Tullio, Vivian
Finesso, Nicole
Comini, Sara
Bressan, Bruno Emilio
Pecoraro, Francesca
Giribaldi, Giuliana
Troia, Adriano
Cavalli, Roberta
Cuffini, Anna Maria
Banche, Giuliana
Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title_full Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title_fullStr Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title_full_unstemmed Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title_short Antibacterial and Antifungal Efficacy of Medium and Low Weight Chitosan-Shelled Nanodroplets for the Treatment of Infected Chronic Wounds
title_sort antibacterial and antifungal efficacy of medium and low weight chitosan-shelled nanodroplets for the treatment of infected chronic wounds
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015045/
https://www.ncbi.nlm.nih.gov/pubmed/35444418
http://dx.doi.org/10.2147/IJN.S345553
work_keys_str_mv AT mandrasnarcisa antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT argenzianomonica antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT pratomauro antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT roanajanira antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT luganinianna antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT allizondvaleria antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT tulliovivian antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT finessonicole antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT cominisara antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT bressanbrunoemilio antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT pecorarofrancesca antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT giribaldigiuliana antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT troiaadriano antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT cavalliroberta antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT cuffiniannamaria antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds
AT banchegiuliana antibacterialandantifungalefficacyofmediumandlowweightchitosanshellednanodropletsforthetreatmentofinfectedchronicwounds